Insight Molecular Diagnostics, Inc. (IMDX)
6.15
-0.26
(-4.06%)
USD |
NASDAQ |
May 18, 11:01
Insight Molecular Diagnostics Total Assets (Quarterly) : 40.43M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Veracyte, Inc. | 1.436B |
| Exagen, Inc. | 51.96M |
| bioAffinity Technologies, Inc. | 7.945M |
| GRAIL, Inc. | 2.803B |
| FONAR Corp. | 219.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 51.12M |
| Shareholders Equity (Quarterly) | -10.69M |
| Debt to Equity Ratio | -0.2871 |
| Current Ratio | 2.542 |
| Net Debt Paydown Yield | 0.11% |